Jeffrey Sosman, M.D., professor of Medicine at Vanderbilt-Ingram Cancer Center (VICC), has been named to a melanoma research Dream Team of cancer investigators supported by Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA). Sosman is among the Dream Team’s principal investigators who will work closely to write the genomic-driven clinical trials and […]
News: Personalized Oncology
For decades, cancers have been treated based on how they look under a microscope. Now, researchers know that specific abnormalities in the DNA of tumor cells can make each person’s cancer respond differently to treatment — knowledge that offers an exciting new avenue for tailored therapy. Personalizing cancer treatment for an individual patient based on […]
Dr. William Pao, director of hematology and oncology at Vanderbilt-Ingram Cancer Center, explains what personalized cancer medicine means for the future of lung cancer treatment. Learn more about Personalized Cancer Medicine.
Dr. Carlos Arteaga, director of the Vanderbilt-Ingram Cancer Center’s breast cancer program, describes how advances in personalized cancer medicine contributes to breast cancer treatment.
William Pao, M.D., Ph.D., associate professor of Medicine and director of Personalized Cancer Medicine at Vanderbilt, has been named director of the Division of Hematology and Oncology in the Department of Medicine. “Dr. Pao has demonstrated tremendous leadership and creativity since arriving at Vanderbilt,” said Nancy Brown, M.D., chair and physician-in chief of the Department […]
Breast cancer patients at Vanderbilt-Ingram Cancer Center can now have their tumor tissue tested for gene mutations that are important for treatment decisions. Information from genetic tests in the tumors will be used to match patients to the best cancer therapies available, including drugs that are in early clinical trial testing. Tumor mutation testing for […]
William Pao, M.D., Ph.D., and Fernando Polack, M.D., have been elected into one of the nation’s most respected medical honor societies — the American Society for Clinical Investigation (ASCI). Pao, the Ingram Associate Professor of Cancer Research, and Polack, the Cesar Milstein Associate Professor of Pediatrics, were among 70 new members introduced at the ASCI […]
Mary Zutter, M.D., has been appointed assistant vice chancellor for Integrative Diagnostics at Vanderbilt University Medical Center. In her newly created role, she will guide efforts to apply and integrate the latest advances in biomedical science and technology and emerging diagnostic tests and procedures. The major goal of these efforts is to improve patient care. […]
Vanderbilt-Ingram Cancer Center has launched the nation’s first personalized cancer decision support tool, “My Cancer Genome,” to help physicians and researchers track the latest developments in personalized cancer medicine and connect with clinical research trials for their patients. This web-based information tool is designed to quickly educate clinicians on the rapidly expanding list of genetic […]
Uniting Against Lung Cancer, a nonprofit organization dedicated to funding innovative lung cancer research in the United States and Canada, has awarded a $100,000 grant to Christine Lovly, M.D., Ph.D., a fellow in the Division of Hematology/Oncology at Vanderbilt-Ingram Cancer Center. The two-year grant will fund Lovly’s research on better treatment options for a subset […]
Subscribe to our e-Newsletter to receive email updates: